MRD can prove useful in the treatment of patients with hairy cell leukemia who relapsed.
Frahad Ravandi-Kashani, MD
Advertisement
Articles by Frahad Ravandi-Kashani, MD
Advertisement
Latest Updated Articles
Measurable Residual Disease's Role in the Relapse SettingOctober 29th 2019
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma
2
APAO 2026: Dr. Angela Jia on Navigating Data in Prostate and GU Cancer
3
Daraxonrasib Approved: What Oncology Nurses Must Know About Rasonque
4
Subcutaneous Dosing and Upfront Prophylaxis in EGFR-Mutated NSCLC
5